Global Congenital Hyperinsulinism Market, By Type (Diffuse Hyperinsulinism and Focal Hyperinsulinism), Drug Type (Diiazoxide, Octreotide and Nifedipine), Gender (Males and Females), Route of Administration, (Intravenous, Oral, Parenteral), Mode of Purchase (Prescription and Over the Counter.), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Others.), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028